Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India

Pallavi Madhiraju- June 21, 2023

The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based ... Read More

Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India

Pallavi Madhiraju- May 31, 2023

Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More

Themis Medicare gets DGCI approval for narcotic painkiller REMITHEM

Pallavi Madhiraju- February 17, 2023

Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate ... Read More

Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19

pallavi123- April 5, 2022

Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More

Dr. Reddy’s gets DCGI approval for single-shot Sputnik Light vaccine

pallavi123- February 9, 2022

Dr. Reddy's Laboratories said that the Drugs Controller General of India (DCGI) has approved the single-shot Sputnik Light vaccine for restricted use in emergency situation ... Read More

Aurobindo Pharma gets DCGI nod for Molnupiravir generic version

pallavi123- December 29, 2021

Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More